“We have these issues which we face in Europe. And the solution, I think, is not just to get money to build a factory, you know, or grants to develop products,” vice president of off-patent industry association Medicines for Europe and CEO of Polpharma, Markus Sieger, tells Generics Bulletin during an exclusive interview.
“I think we have to create an ecosystem where we can compete in supplying those products at a fair price....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?